The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Makarova E.V.

Privolzhsky Research Medical University

Senchukova M.A.

Orenburg State Medical University of the Ministry of Health of Russia;
Orenburg Regional Oncology Dispensary

Volchenko N.N.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Tumor microvessels in Stage I-IIA cervical cancer and their clinical significance

Authors:

Makarova E.V., Senchukova M.A., Volchenko N.N.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2021;10(6): 35‑40

Read: 1423 times


To cite this article:

Makarova EV, Senchukova MA, Volchenko NN. Tumor microvessels in Stage I-IIA cervical cancer and their clinical significance. P.A. Herzen Journal of Oncology. 2021;10(6):35‑40. (In Russ.)
https://doi.org/10.17116/onkolog20211006135

Recommended articles:
The phenomenon of tumor budding in gastric cancer. Russian Journal of Archive of Pathology. 2025;(2):79-87
Diagnosis and treatment of ovarian cancer in pregnancy. Russian Bulletin of Obstetrician-Gynecologist. 2025;(3):27-33
Influence of limb reva­scularization and therapeutic angiogenesis on concentration of angiogenic factors. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(5):539-546

References:

  1. Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):191-203.  https://doi.org/10.1016/S2214-109X(19)30482-6
  2. World Source: Globocan 2018. https://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf
  3. Kaprin AD, Starinskii VV, Petrova GV, eds. Malignant neoplasms in Russia in 2018 (morbidity and mortality). M.: MNIOI im.P.A. Gertsena — filial FGBU «NMIRTs» Minzdrava Rossii; 2019. (In Russ.). https://www.oncology.ru/service/statistics/malignant_tumors/2018.pdf
  4. Maiborodin IV, Krasilnikov SE, Kozjakov AE, et al. The Feasibility of Tumor-Related Angiogenesis Study as a Prognostic Factor for Cancer Development. Novosti Khirurgii. 2015;3(23):339-347. (In Russ.).
  5. Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992;267(16): 10931-10934.
  6. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86(3):353-364.  https://doi.org/10.1016/s0092-8674(00)80108-7
  7. Yehya AHS, Asif M, Petersen SH, et al. Angiogenesis: Managing the Culprits behind Tumorigenesis and Metastasis. Medicina (Kaunas). 2018;54(1):8.  https://doi.org/10.3390/medicina54010008
  8. Vartanyan AA. Basic mechanisms of angiogenesis in hematological malignancies Klinicheskaya onkogematologiya. Fundamental’nye issledovaniya i klinicheskaya praktika. 2013;4(6):343-353. (In Russ.).
  9. Vermeulen PB, Gasparini G, Fox SB, et al. Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer. 1996;32A(14):2474-2484. https://doi.org/10.1016/s0959-8049(96)00379-6
  10. Yao X, Qian CN, Zhang ZF, et al. Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications. Clin Cancer Res. 2007;13(1):161-169.  https://doi.org/10.1158/1078-0432.CCR-06-0774
  11. Szafarowski T, Sierdzinski J, Szczepanski MJ, Whiteside TL, Ludwig N, Krzeski A. Microvessel density in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2018;275(7):1845-1851. https://doi.org/10.1007/s00405-018-4996-2
  12. Şener E, Şipal S, Gündoğdu C. Comparison of Microvessel Density with Prognostic Factors in Invasive Ductal Carcinomas of the Breast. Comparison of Microvessel Density with Prognostic Factors in Invasive Ductal Carcinomas of the Breast. Turk Patoloji Derg. 2016;32(3):164-170.  https://doi.org/10.5146/tjpath.2016.01366
  13. Zand B, Coleman RL, Sood AK. Targeting angiogenesis in gynecologic cancers. Hematol Oncol Clin North Am. 2012;26(3):543-viii. https://doi.org/10.1016/j.hoc.2012.01.009
  14. Vieira SC, Zeferino LC, Da Silva BB, et al. Quantification of angiogenesis in cervical cancer: a comparison among three endothelial cell markers. Gynecol Oncol. 2004;93(1):121-124.  https://doi.org/10.1016/j.ygyno.2004.01.033
  15. Moriyama S, Kotera K, Khan KN, et al. Prognostic significance of tumor volume and microvessel density in squamous cell carcinoma of uterine cervix. Acta Med Nagasakiensia. 2009;53(4):77-84. 
  16. van der Veldt AA, Hooft L, van Diest PJ, et al. Microvessel density and p53 in detecting cervical cancer by FDG PET in cases of suspected recurrence. Eur J Nucl Med Mol Imaging. 2006;33(12):1408-1416. https://doi.org/10.1007/s00259-006-0108-4
  17. Vieira SC, Silva BB, Pinto GA, et al. CD34 as a marker for evaluating angiogenesis in cervical cancer. Pathol Res Pract. 2005;201(4):313-318.  https://doi.org/10.1016/j.prp.2005.01.010
  18. Zhang Q, Li W, Kanis MJ, et al. Oncologic and obstetrical outcomes with fertility-sparing treatment of cervical cancer: a systematic review and meta-analysis. Oncotarget. 2017;8(28):46580-46592. https://doi.org/10.18632/oncotarget.16233
  19. Kravec OA, Kuznecov VV, Morhov KYu, Nechushkina VM, Hohlova SV. Rak shejki matki. Klinicheskie rekomendacii po diagnostike i lecheniyu. M. 2018. (In Russ.).
  20. Hohlova SV, Kolomiec LA, Kravec OA, Morhov KY, Nechushkina VM, Novikova EG, Tyulyandina AS, Urmancheeva AF. Prakticheskie rekomendacii po lekarstvennomu lecheniyu raka shejki matki. Prakticheskie rekomendacii RUSSCO. Zlokachestvennye opuholi. 2020;10:3s2-1. (In Russ.). https://doi.org/10.18027/2224-5057-2020-10-3s2-13
  21. Kajrbaev MR. Faktory prognoza mestnorasprostranennogo raka shejki matki. Sibirskij onkologicheskij zhurnal. 2009;4(34):32-35. (In Russ.).
  22. Gus’kova EA, Nerodo GA, Gus’kova NK, Poryvaev YuA, Chernikova NV. Faktory, vliyayushchie na chastotu recidivirovaniya raka shejki matki. Mezhdunarodnyj zhurnal prikladnyh i fundamental’nyh issledovanij. 2015;10(1):87-91. (In Russ.).
  23. Wen HW, Huang WP, Liu TY, et al. Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors. Zhonghua Fu Chan Ke Za Zhi. 2013;48(12):920-924. PMID: 24495686.
  24. Anfinan N, Sait K. Indicators of survival and prognostic factors in women treated for cervical cancer at a tertiary care center in Saudi Arabia. Ann Saudi Med. 2020;40(1):25-35.  https://doi.org/10.5144/0256-4947.2020.25

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.